Literature DB >> 4150760

Assessment of selective beta-adrenoceptor blockade in man.

R H Briant, C T Dollery, T Fenyvesi, C F George.   

Abstract

1. Selective antagonism of the cardiac beta(1)-adrenoceptors has been studied in normal human volunteers.2. Practolol and UK 6558 produced greater antagonism of the chronotropic and inotropic responses to i.v. isoprenaline than of the vasodilator response to either i.v. or intra-arterial isoprenaline. A third drug, M&B 17,803A, produced non-selective beta-adrenoceptor blockade in 2 of 3 subjects studied.3. Practolol, UK 6558 and M&B 17,803A, produced an attenuation of the responses to Valsalva's manoeuvre.4. A substantial reduction in blood pressure was seen in 3 of 4 normotensive subjects given UK 6558.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4150760      PMCID: PMC1776418          DOI: 10.1111/j.1476-5381.1973.tb08272.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Cardio-selective beta-blockade.

Authors:  A M Barrett; A F Crowther; D Dunlop; R G Shanks; L H Smith
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

2.  Unwanted effects of propranolol.

Authors:  S A Stephen
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

5.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

6.  Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.

Authors:  M Ulrych; E D Frohlich; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

7.  The paradox of beta-adrenergic blockade in hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

8.  Comparison of propranolol and I.C.I. 50,172 on isoprenaline-induced increase in skin temperature in man.

Authors:  J Harrison; P Turner
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

9.  Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.

Authors:  B Levy
Journal:  Br J Pharmacol Chemother       Date:  1966-08

10.  Effects of a cardio-selective beta-adrenergic blocker (I.C.I. 50172) at exercise in angina pectoris.

Authors:  N H Areskog; L Adolfsson
Journal:  Br Med J       Date:  1969-06-07
View more
  22 in total

1.  Problems in assessing beta-adrenoceptor antagonism in man.

Authors:  C F George
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

Review 2.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 3.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

4.  Exercise responses of healthy subjects in the evaluation of cardioselectivity of beta-blockers.

Authors:  K L Woods; S P Linton; M J Kendall; E B Faragher; R J Grieve
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

5.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  J M Arnold; P C O'Connor; J G Riddell; D W Harron; R G Shanks; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

6.  Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.

Authors:  P A Routledge; L V Zrinzo; J G Rao; R J Walden; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

7.  Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.

Authors:  G Jackson; L Atkinson; S Oram
Journal:  Br Med J       Date:  1975-03-29

8.  Catecholamine sensitivity in hyperthyroidism and hypothyroidism.

Authors:  D G McDevitt; J G Riddell; D R Hadden; D A Montgomery
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

9.  Pharmacokinetics of tolamolol in the treatment of hypertension.

Authors:  P A Routledge; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

10.  Bioavailability of tolamolol.

Authors:  J K Faulkner; D A Stopher; R Walden; W Singleton; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.